Xarelto for Real Life Anticoagulation in Pulmonary Embolism (PE) in China (XAPEC)
Xarelto® for Real Life Anticoagulation in Pulmonary Embolism (PE) in China
Sponsor: Bayer
This observational or N/A phase trial investigates Pulmonary Embolism and is currently completed. Bayer leads this study, which shows 48 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
48 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2023 — Jul 2024 [monthly]
Completed
-
Feb 2022 — Jan 2023 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jan 2022 — Feb 2022 [monthly]
Active Not Recruiting
▶ Show 43 earlier versions
-
Dec 2021 — Jan 2022 [monthly]
Active Not Recruiting
-
Nov 2021 — Dec 2021 [monthly]
Active Not Recruiting
-
Oct 2021 — Nov 2021 [monthly]
Active Not Recruiting
-
Sep 2021 — Oct 2021 [monthly]
Active Not Recruiting
-
Jun 2021 — Sep 2021 [monthly]
Active Not Recruiting
-
May 2021 — Jun 2021 [monthly]
Active Not Recruiting
-
Apr 2021 — May 2021 [monthly]
Active Not Recruiting
-
Mar 2021 — Apr 2021 [monthly]
Active Not Recruiting
-
Feb 2021 — Mar 2021 [monthly]
Active Not Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Nov 2020 — Dec 2020 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Oct 2020 — Nov 2020 [monthly]
Recruiting
-
Sep 2020 — Oct 2020 [monthly]
Recruiting
-
Aug 2020 — Sep 2020 [monthly]
Recruiting
-
Jul 2020 — Aug 2020 [monthly]
Recruiting
-
Jun 2020 — Jul 2020 [monthly]
Recruiting
-
May 2020 — Jun 2020 [monthly]
Recruiting
-
Apr 2020 — May 2020 [monthly]
Recruiting
-
Mar 2020 — Apr 2020 [monthly]
Recruiting
-
Jan 2020 — Mar 2020 [monthly]
Recruiting
-
Dec 2019 — Jan 2020 [monthly]
Recruiting
-
Nov 2019 — Dec 2019 [monthly]
Recruiting
-
Oct 2019 — Nov 2019 [monthly]
Recruiting
-
Sep 2019 — Oct 2019 [monthly]
Recruiting
-
Aug 2019 — Sep 2019 [monthly]
Recruiting
-
Jul 2019 — Aug 2019 [monthly]
Recruiting
-
Jun 2019 — Jul 2019 [monthly]
Recruiting
-
May 2019 — Jun 2019 [monthly]
Recruiting
-
Apr 2019 — May 2019 [monthly]
Recruiting
-
Mar 2019 — Apr 2019 [monthly]
Recruiting
-
Feb 2019 — Mar 2019 [monthly]
Recruiting
-
Jan 2019 — Feb 2019 [monthly]
Recruiting
-
Dec 2018 — Jan 2019 [monthly]
Recruiting
-
Nov 2018 — Dec 2018 [monthly]
Recruiting
-
Oct 2018 — Nov 2018 [monthly]
Recruiting
-
Sep 2018 — Oct 2018 [monthly]
Recruiting
-
Aug 2018 — Sep 2018 [monthly]
Recruiting
-
Jul 2018 — Aug 2018 [monthly]
Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2018 — Mar 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Bayer
- Janssen Research & Development, LLC
For direct contact, visit the study record on ClinicalTrials.gov .